Quality of artemisinin-based combination formulations for malaria treatment: Prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Kaur, Harparkash ^a   Allan, Elizabeth Louise ^a   Mamadu, Ibrahim ^a   Hall, Zoe ^a   Ibe, Ogochukwu ^b   Sherbiny, Mohamed El ^a   Van Wy, Albert ^a   Yeung, Shunmay ^a   Swamidoss, Isabel ^c   Green, Michael D ^c   Dwivedi, Prabha ^c   Culzoni, Maria Julia ^d   Clarke, Siân ^a   Schellenberg, David ^a   Fernández, Facundo M ^e   Onwujekwe, Obinna ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF NIGERIA   (Nigeria)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^e GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER; ARTEMISININ; ARTESUNATE; BENFLUMETOL; DIHYDROARTEMISININ; MEFLOQUINE; PIPERAQUINE; PYRIMETHAMINE; SULFADOXINE; SULFAMETHOXYPYRIDAZINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; TABLET;

ARTICLE; CONTENT ANALYSIS; CONTROLLED STUDY; CONVENIENCE SAMPLE; DRUG QUALITY; HEALTH CARE FACILITY; HUMAN; MALARIA; NIGERIA; PHARMACY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; WORLD HEALTH ORGANIZATION; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALARIA, FALCIPARUM; PRIVATE SECTOR; QUALITY CONTROL; SANITATION; STANDARDS; TABLET;

ANTIMALARIALS; ARTEMISININS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MALARIA, FALCIPARUM; NIGERIA; PHARMACIES; PRIVATE SECTOR; PUBLIC FACILITIES; QUALITY CONTROL; RISK FACTORS; TABLETS;

EID: 84937243957     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125577     Document Type: Article

References (30)

1. WHO malaria report 2013. Available: http://www.who.int/malaria/publications/world-malaria-report- 2013/en/. Accessed 2014 Feb 25.
2. Chaccour CJ, Kaur H, Mabey D, et. al. (2012) Travel and fake artesunate: a risky business. Lancet, Sep 22; 380(9847).
3. Newton PN, Amin AA, Bird C, Passmore P, Dukes G, Tomson G, et. al. (2011) "The primacy of public health considerations in defining poor quality medicines" PLoS -One, 8, e1001139.
4. Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, et. al. (2001) Fake artesunate in Southeast Asia. Lancet 357, 1948-1950. PMID: 11425421
5. Phanouvong S, Reiss, et. al. (July 1-5, 2005) Why be concerned about the quality of antimalarial and ARV drugs? Poster presentation at 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan.
6. Rozendaal JA (2001) Fake antimalaria drugs in Cambodia. The Lancet 357: 890.
7. Aldhous P (2005). Murder by Medicines, News Feature. Nature 434,132-6. PMID: 15758966
8. Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, Bruneton C, et al. (2006) Manslaughter by Fake Artesunate in Asia-Will Africa Be Next? PLoS Medicine 3, 6, e197.
9. Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, Sokhan C, et. al. (2006) Counterfeit and Substandard Anti-Malarial Drugs in Cambodia. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 1019-1024. PMID: 16765399
10. Newton PN, Green MD, Mildenhall DC, Plançon A, Nettey H, Nyadong L, et al. (2011) Poor quality vital anti-malarials in Africa-an urgent neglected public health priority. Malar J. Dec 13; 10:352. doi: 10. 1186/1475-2875-10-352 PMID: 22152094
11. Malaria Operational Plan Nigeria, President0 s Malaria Initiative 2013. Available: http://www.pmi.gov/ countries/profiles/nigeria.html. Accessed 2014 Dec 2.
12. Nigeria: DHS, 2008-Final Report. Available: http://www.measuredhs.com/pubs/pdf/FR222/FR222-pdf. Accessed 2014 Feb 12.
13. Federal Ministry of Health, National Malaria Control Programme, Abuja Nigeria. Strategic Plan 2009-2013
14. Onwujekwe O, Kaur H, Dike N, Shu E, Uzochukwu B, Hanson K, et. al. (2009) Quality of anti-malarial drugs provided by public and private healthcare providers in southeast Nigeria. Malar J. 8(1):22.
15. Newton PN, Lee SJ, Goodman C, Fernández FM, Yeung S, Phanouvong S, et. al. (2009) Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 24; 6(3):e52. doi: 10.1371/journal. pmed.1000052 PMID: 19320538
16. Almuzaini T, Choonara I and Sammons H (2013) Substandard and Counterfeit medicines: a systematic review of the literature. BMJ Open 3: e002923. doi: 10.1136/bmjopen-2013-002923 PMID: 23955188
17. Available: http://www.map.ox.ac.uk/browse-resources/endemicity/Pf-mean/NGA/. Accessed 2014 Mar 25.
18. United States Pharmacopeia-Guidelines for sampling of Antimalarial drug Samples in the USP DQ1 Antimalarial Drug quality Monitoring Project in Mekong Sub-region countries. (2001) Available: http:// pdf.usaid.gov/pdf-docs/PNADH150.pdf. Accessed 2014 Oct 14.
19. Mangham LJ, Cundill B, Ezeoke O, Nwala E, Uzochukwu BS, Wiseman V, et al. (2011) Treatment of uncomplicated malaria at public health facilities and medicine retailers in south-eastern Nigeria. Malar J, 10: 155. doi: 10.1186/1475-2875-10-155 PMID: 21651787
20. Available: http://epi-info.software.informer.com/3.5/. Accessed 2014 Aug 25.
21. Monge ME, Harris GA, Dwivedi P, Fernández FM (2013) "Mass Spectrometry: Recent Advances in Direct Open Air Surface Sampling/Ionization". Chem Rev 113(4): 2269-2308. doi: 10.1021/cr300309q PMID: 23301684
22. Culzoni MJ, Dwivedi P, Green MD, Newton PN, Fernández FM (2014) Ambient mass spectrometry technologies for the detection of falsified drugs. Med chem comm, 5(1): 9-19.
23. Blessy M, Patel RD, Prajapati PN, Agrawal YK (2014) Development of forced degradation and stability indicating studies of drugs-A review. J Pharmaceutical Analysis 4(3) 159-165.
24. Tabernero P, Fernandez FM, Green M, Guerin PJ, Newton PN (2014) Mind the gaps-the epidemiology of poor-quality anti-malarials in the malarious world-analysis of the WorldWide Antimalarial Resistance Network database. Malar J, 13:139 doi: 10.1186/1475-2875-13-139 PMID: 24712972
25. Nayyar GMI, Breman JG, Newton PN (2012) Poor-quality antimalarial drugs in Southeast Asia and sub-Saharan Africa. Lancet Infect Dis, 12: 488-96. doi: 10.1016/S1473-3099(12)70064-6 PMID: 22632187
26. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. (2014) Spread of Artemisinin Resistance in Plasmodium falciparum Malaria. New Eng J Med 371: 411-423. doi: 10.1056/ NEJMoa1314981 PMID: 25075834
27. Faucon B, Murphy C, Whalen J. Africa\'s Malaria Battle: Fake Drug Pipeline Undercuts Progress. Wall Street Journal May 29th 2013. Available: http://online.wsj.com/article/ SB10001424127887324474004578444942841728204.html. Accessed 2014 Jul 16.
28. Newton PN, Tabernero P, Dwivedi P, Culzoni MJ, Monge ME, Swamidoss I, et al. (2014) Falsified medicines in Africa: all talk, no action. Lancet Glob Health 2(9): e509-10. doi: 10.1016/S2214-109X(14) 70279-7 PMID: 25304415
29. Available: https://thecounterfeitreport.com/product/395/Novartis-Coartem-Malaria-Drugs.html. Accessed 2014 Nov 20.
30. Roberts M (2012) Third of malaria drugs \'are fake\' Available: www.bbc.co.uk/news/health-18147085. Accessed 2014 Apr 14.